Tabula Rasa HealthCare moves its San Francisco-based Operations to a Larger, Technologically Advanced Facility

Loading...
Loading...

MOORESTOWN, N.J., Feb. 20, 2017 (GLOBE NEWSWIRE) -- Tabula Rasa HealthCare TRHC, a healthcare technology company providing medication safety solutions for health plans and provider groups, including the Centers for Medicare and Medicaid Services' (CMS) Program for All-Inclusive Care of the Elderly (PACE), has relocated its California medication decision support and robotic dispensary.

According to TRHC Chairman and CEO Calvin H. Knowlton, PhD, "We were in need of a larger, more technologically-advanced facility that could accommodate our growth trajectory, and our proprietary science and technology Medication Risk Mitigation products and services," said Knowlton.

The practice, acquired by TRHC in 2014, had been servicing the needs of frail elderly PACE participants in the San Francisco and Bay Area for over 35 years.  Its focus on participant care and customer service has earned it its long-term partnerships. The former owner remains with the company as part of its West Coast Operations.  

About Tabula Rasa HealthCare
Tabula Rasa HealthCare TRHC is a leader in providing patient-specific, data-driven technology and solutions that enable healthcare organizations to optimize medication regimens to improve patient outcomes, reduce hospitalizations, lower healthcare costs and manage risk.  Medication risk management is TRHC's lead offering, and its cloud-based software applications provide solutions for a range of payers, providers and other healthcare organizations. For more information, please visit: www.trhc.com.

Contact:

Media
Dianne Semingson
dsemingson@TRHC.com
T: 215-870-0829

Investors
Bob East or Asher Dewhurst
Westwicke Partners
443-213-0500
tabularasa@westwicke.com

Loading...
Loading...
Market News and Data brought to you by Benzinga APIs
Posted In: Press Releases
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

Loading...